Context
Recently, the Union Minister of Agriculture and Farmers Welfare and Rural Development, Shri Shivraj Singh Chouhan, dedicated India’s first indigenous Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens to the Nation on 20 November 2026 at ICAR-NIHSAD, Bhopal.
About India’s Indigenous H5N1 Vaccine
- Developed By: ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal.
- Venue & Dedication: ICAR-NIHSAD, Bhopal, on 20 November 2026.
- Vaccine Type: Inactivated H5N1 Highly Pathogenic Avian Influenza (HPAI) vaccine developed specifically for chickens.
- Target Strain: Clade 2.3.2.1a of the H5N1 virus, which is responsible for most bird flu outbreaks in chickens in India.
- Objective: Protect poultry against circulating Clade 2.3.2.1a H5N1 strains, curb financial losses for farmers, and prevent transmission to other animals and humans.
Major Highlights
- Severity of HPAI (Bird Flu): A serious viral disease affecting chickens and other birds that can cause nearly 100% mortality among infected birds, leading to large-scale culling and trade restrictions.
- Outbreak History in India: Since its first detection in India in 2006, more than 500 combined outbreaks of H5N1 and H5N8 subtypes have been reported.
- Economic Impact: A major outbreak could reduce India’s GDP growth by up to 1.5% and put over 20% of the poultry population at risk; the 2006 outbreak caused estimated losses of ₹2,200–3,000 crore, while an outbreak in Manipur caused losses equivalent to 0.5% of the state’s GDP.
- Zoonotic & Public Health Concern: Clade 2.3.2.1a infections have recently been detected in mammals and humans; according to the WHO, 1,003 human cases of H5N1 (including 479 deaths) have been reported across 25 countries, including India, since 2003.
- Addressing a Critical Gap: No specific commercial vaccine was previously available against the H5N1 Clade 2.3.2.1a virus in the country.
Significance
- Protection of Poultry Farms: Helps control bird flu outbreaks and significantly reduces poultry mortality.
- Economic Security & Livelihoods: Safeguards poultry farmers and allied businesses from financial losses caused by culling, price disruptions, and trade restrictions.
- Public Health: Containing the virus in poultry reduces the risk of zoonotic spillover to mammals and humans.
- Preparedness: Strengthens India’s institutional capacity to respond swiftly to animal disease outbreaks.
Conclusion
India’s first indigenous H5N1 (Clade 2.3.2.1a) vaccine marks a vital milestone in animal disease management, protecting the poultry sector, farmers’ livelihoods, and public health while advancing self-reliance in veterinary healthcare.
| Important CTC from this Article: H5 N1 Bird Flu |